Recombinant Human C1 Inhibitor (rHC1INH) Is Efficacious and Well Tolerated As Prophylaxis for Prevention of Hereditary Angioedema (HAE) Attacks: A Randomized, Phase 2 Trial

Authors:
  • WYWilliam H. Yang
    William H. Yang
  • HLH.H. Li
    H.H. Li
  • CCChevy Chase
    Chevy Chase
  • DMD. Moldovan
    D. Moldovan
  • VGV. Grivcheva-Panovska
    V. Grivcheva-Panovska
  • JHJ.R. Harper
    J.R. Harper
  • MRMarc A. Riedl
    Marc A. Riedl

Abstract
No abstract available